Company Number: 13591808

Analysis Date: 2025-07-20 15:46 UTC

Financial Health Assessment of ON THE EDGE LIMITED

---

1. Financial Health Score: D

Explanation:
The company exhibits significant signs of financial distress, primarily due to persistent negative working capital and a dramatic erosion of net assets over recent years. While still operational and meeting filing deadlines, the balance sheet reveals a precarious liquidity position and minimal shareholder equity. This score reflects a need for urgent financial restructuring and improved cash flow management to avoid insolvency risks.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	29,758	Relatively low asset base, modest investment in long-term resources.
Current Assets	13,564	Limited short-term resources available for daily operations.
Current Liabilities	43,321	High short-term debts creating liquidity pressure.
Net Current Assets (Working Capital)	-29,757	Negative working capital indicates the company cannot cover short-term liabilities with current assets—symptom of liquidity stress.
Net Assets (Shareholders’ Equity)	1	Drastic reduction from £7,224 in 2023 to just £1 in 2024, showing near depletion of company’s net worth—critical warning sign.
Shareholders Funds	1	Equity buffer almost wiped out, increasing risk of insolvency.

Additional Notes:

• The company’s negative working capital is like a patient with a dangerously low blood pressure; the business lacks the immediate liquidity "oxygen" to sustain day-to-day operations comfortably.
• The sharp decline in net assets suggests ongoing losses or write-downs, indicating the business "body" is deteriorating internally.
• Director loans show some complexity: advances to directors have been largely repaid or reduced, but this reflects internal financial juggling rather than external financial health.

---

3. Diagnosis

ON THE EDGE LIMITED is currently in a fragile financial state characterized by:

• Liquidity Crisis: The negative net current assets (-£29,757) reveal that the company’s short-term obligations exceed its short-term resources significantly, a classical symptom of cash flow distress. This condition can lead to an inability to pay suppliers or creditors on time, which may escalate into insolvency if unaddressed.

• Equity Erosion: The near wipeout of net assets from £7,224 to £1 suggests accumulated losses or write-offs over the year, indicating the company’s financial "immune system" is severely weakened. This means the business has very little financial cushion to absorb further losses or shocks.

• Asset Base Shrinkage: Fixed assets have decreased from £39,996 to £29,758, possibly due to disposals or impairments, reducing the company's long-term stability and capacity to generate future revenue.

• Operational Scale: As a micro-entity with only about 2 employees, the company operates on a very small scale, which may limit its ability to weather financial storms or invest in growth.

In medical terms, the company is showing "symptoms of distress" with a declining "vital sign" profile—its financial health is compromised, and without intervention, the prognosis may worsen.

---

4. Recommendations

To improve ON THE EDGE LIMITED’s financial wellness and stabilize its position, the following steps are advised:

1. Improve Liquidity Management:

   • Accelerate collection of receivables and optimize inventory to boost current assets.
   • Negotiate with creditors for extended payment terms to reduce immediate liabilities.
   • Consider short-term financing options carefully to bridge liquidity gaps but avoid excessive debt.

2. Cost Control and Profitability Enhancement:

   • Conduct a thorough review of operating expenses to identify and cut non-essential costs.
   • Explore pricing strategies or diversify services/products to improve margins.
   • Monitor cash flow closely with regular forecasting to anticipate and manage shortfalls.

3. Capital Injection or Restructuring:

   • Engage shareholders or investors to inject fresh equity capital to rebuild net assets and provide financial cushioning.
   • If equity injection is not feasible, explore restructuring options to manage liabilities and improve balance sheet strength.

4. Strategic Business Review:

   • Assess the viability of current business activities given the SIC code (Other manufacturing) and explore potential pivot or niche markets with better profitability.
   • Invest cautiously in fixed assets to avoid further asset erosion and preserve cash.

5. Governance and Financial Oversight:

   • Strengthen financial controls and reporting to detect early "symptoms" of distress in future periods.
   • Directors should maintain transparent communication with stakeholders about financial challenges and plans.

---